Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03578549 · ClinicalTrials.gov registry record
Diagnostic Device for the Assessment of Pulpal Blood Flow
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 30
- Enrollment target
NCT03578549: Completed study, sponsored by University of Michigan.
NCT03578549 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03578549 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to assess tooth health by using a pulse oximeter which measures the blood flow within the tooth. This method is not currently being used in dentistry. We hypothesize that if we can measure both sensation and blood flow in a tooth, we will be able to better determine if the tooth is "alive or dead". In the future, this method may help determine which teeth are diseased and require dental treatments.
Primary Outcome
Conventional subjective tooth assessments (percussion, palpation, cold, and electrical pulp testing) will be used for teeth that are planned for extraction and also upto 2-5 additional teeth in each participant. Pulp status is determined as "normal" or "abnormal" according to the classification system from the American Academy of Endodontics.
Interventions
- DEVICE Pulse Oximetry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2019-06-30 |
What the finished NCT03578549 record still lists
NCT03578549 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pulse Oximetry is the first listed.
NCT03578549 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03578549 about?
NCT03578549 is a clinical study titled "Diagnostic Device for the Assessment of Pulpal Blood Flow". The purpose of this study is to assess tooth health by using a pulse oximeter which measures the blood flow within the tooth. This method is not currently being used in dentistry. We hypothesize that if we can measure both sensation and blood flow in a tooth, we will be able to better determine if t...
What is the current status of trial NCT03578549?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2018-07-12. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03578549?
The interventions under investigation include: Pulse Oximetry (DEVICE).
Who is sponsoring clinical trial NCT03578549?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI